EDGAR Filing Documents for 0001654954-19-008399

Form 8-K - Current report:

SEC Accession No. 0001654954-19-008399

Filing Date

2019-07-22

Accepted

2019-07-22 17:28:45

Documents

Period of Report

2019-07-17

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	azrx8k_july172019.htm	8-K	41001
2	UNDERWRITING AGREEMENT	ex1-1.htm	EX-1.1	209027
3	FORM OF WAINWRIGHT WARRANT	ex4-1.htm	EX-4.1	159151
4	OPINION OF DISCLOSURE LAW GROUP, A PROFESSIONAL CORPORATION	ex5-1.htm	EX-5.1	10376
5	IMAGE	dlg.jpg	GRAPHIC	7666
6	IMAGE	ex99-1000.jpg	GRAPHIC	2983
	Complete submission text file	0001654954-19-008399.txt		435750

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226

Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855

AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 19966443
SIC: 2834 Pharmaceutical Preparations